Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;

The burden of hepatic encephalopathy and the use of albumin as a potential treatment Jasmohan S. Bajaj; Enrico Pompili; Paolo Caraceni;

The rationale for the aggressive progression of MASLD in patients with type 2 diabetes Valeria Michelle Fernández-Garibay; Norberto C. Chavez-Tapia;